Oct. 8 at 1:44 PM
Join us today at 11:00 AM ET for the virtual Skyline Signature Series, featuring Cuprina Wound Care Solutions (Nasdaq
$CUPR).
David Quek, CEO of Cuprina, will discuss the company’s innovative approach to chronic wound care, including its flagship MEDIFLY® sterile larvae bio-dressing and pipeline of collagen-based biomedical solutions.
Don’t miss this opportunity to hear directly from leadership and learn more about Cuprina’s growth strategy and market vision. 🔗 Register here to join the live event: https://us02web.zoom.us/webinar/register/WN_wWWf2nr8QZmKgzx7IaKrXA#/registration
#SkylineSignatureSeries #InvestorRelations #Biotech #Cuprina #HealthcareInnovation #WoundCare #SkylineCCG #Healthcare
Skyline is paid by
$CUPR for IR services. Disclaimer 17(b): http://skylineccg.com/disclosures/